ropivacaine has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Qin, A; Wang, J | 1 |
| Bae, DS; Chai, YJ; Choi, JY; Kim, SJ; Koo, do H; Kwon, H; Lee, KE; Paek, SH; Youn, YK | 1 |
1 trial(s) available for ropivacaine and Thyroid Neoplasms
| Article | Year |
|---|---|
Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain.
Topics: Adult; Amides; Analgesics; Anesthetics, Local; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Robotic Surgical Procedures; Ropivacaine; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy | 2016 |
1 other study(ies) available for ropivacaine and Thyroid Neoplasms
| Article | Year |
|---|---|
Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha2; Ropivacaine; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2020 |